Skip to content

Clinical study to assess the effectiveness of Khadir Vati in management of vaginal white discharge.

A randomised standard controlled clinical trial to assess the efficacy of Khadir vati in the management of Shwetpradar

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049194
Enrollment
64
Registered
2023-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Sponsors

PDEA College Of Ayurveda and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients having clinical signs and symptoms of Shwetpradara Yoni Kandu(Itching Vulva) Yoni Daha(Burning) Yoni Srava(Shwetpradar) Lower Abdominal Pain Low Backache

Exclusion criteria

Exclusion criteria: Pregnant Women Any type of chronic systemic disorders-TB Cancer Patients consuming Oral Contraceptive Pills

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Khadir Vati and Nagkeshar vati follow up wise result before and after treatment in the management of Shwetpradar with help of Case Record Proforma and Clinical examinationTimepoint: 14 days treatment with two follow ups on 7th and 14th day

Secondary

MeasureTime frame
To study the side effect of drugs if anyTimepoint: 14 days

Countries

India

Contacts

Public ContactNikita Sharadrao Mahajan

PDEA College Of Ayurveda and Research Centre

drvkshinde@yahoo.com9850933512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026